It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) is the most common causative agent of acute bacterial skin and skin-structure infections (ABSSSI), one of the major challenges to the health system worldwide. Although the use of antibiotics as the first line of intervention for MRSA-infected wounds is recommended, important side effects could occur, including cytotoxicity or immune dysregulation, thus affecting the repair process. Here, we show that the oxazolidinone antibiotic linezolid (LZD) impairs wound healing by aberrantly increasing interleukin 1 β (IL-1β) production in keratinocytes. Mechanistically, LZD triggers a reactive oxygen species (ROS)-independent mitochondrial damage that culminates in increased tethering between the endoplasmic reticulum (ER) and mitochondria, which in turn activates the NLR family pyrin domain-containing 3 (NLRP3) inflammasome complex by promoting its assembly to the mitochondrial surface. Downregulation of ER-mitochondria contact formation is sufficient to inhibit the LZD-driven NLRP3 inflammasome activation and IL-1β production, restoring wound closure. These results identify the ER-mitochondria association as a key factor for NLRP3 activation and reveal a new mechanism in the regulation of the wound healing process that might be clinically relevant.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Orlando, Fiorenza 4 ; Missiroli, Sonia 3
; D’Achille, Gloria 2 ; Perrone, Mariasole 3
; Spadoni, Tatiana 5 ; Graciotti, Laura 5
; Bigossi, Giorgia 6
; Provinciali, Mauro 6 ; Offidani, Annamaria 7 ; Mattioli-Belmonte, Monica 8 ; Cirioni, Oscar 9 ; Pinton, Paolo 3
; Simonetti, Oriana 7 ; Marchi, Saverio 8
1 Marche Polytechnic University, Department of Clinical and Molecular Sciences, Ancona, Italy (GRID:grid.7010.6) (ISNI:0000 0001 1017 3210)
2 Marche Polytechnic University, Microbiology Unit, Department of Biomedical Sciences and Public Health, Ancona, Italy (GRID:grid.7010.6) (ISNI:0000 0001 1017 3210)
3 University of Ferrara, Department of Medical Sciences, Laboratory for Technologies of Advanced Therapies (LTTA), Ferrara, Italy (GRID:grid.8484.0) (ISNI:0000 0004 1757 2064)
4 Scientific Technological Area, IRCCS INRCA, Experimental Animal Models for Aging Research, Ancona, Italy (GRID:grid.8484.0)
5 Marche Polytechnic University, Department of Biomedical Sciences and Public Health, Ancona, Italy (GRID:grid.7010.6) (ISNI:0000 0001 1017 3210)
6 IRCCS INRCA, Advanced Technology Center for Aging Research, Ancona, Italy (GRID:grid.7010.6)
7 Marche Polytechnic University, Clinic of Dermatology, Department of Clinical and Molecular Sciences, Ancona, Italy (GRID:grid.7010.6) (ISNI:0000 0001 1017 3210)
8 Marche Polytechnic University, Department of Clinical and Molecular Sciences, Ancona, Italy (GRID:grid.7010.6) (ISNI:0000 0001 1017 3210); IRCCS INRCA, Advanced Technology Center for Aging Research, Ancona, Italy (GRID:grid.7010.6)
9 Marche Polytechnic University, Clinic of Infectious Diseases, Department of Biomedical Sciences and Public Health, Ancona, Italy (GRID:grid.7010.6) (ISNI:0000 0001 1017 3210)




